Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: Dabrafenib/Trametinib, BRAF or BRAF AND MEK Pre-op With BRAF and MEK Post-op, Phase IIB, Melanoma With Brain Mets,Biomarkers and Metabolites [Phase 2]
Phase II study evaluating dabrafenib and trametinib as pre- and post-operative therapy in melanoma patients with brain metastases; the trial…
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: COPARIME: Pilot Study of a Target Detection of Malignant Melanoma [NA]
Pilot study COPARIME evaluating target detection of malignant melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers
This clinical trial update notes the termination of the study evaluating the NantHealth GPS Cancer Test in patients with advanced cancers. T…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Single-arm Trial to Evaluate the Role of the Immune Response to Talimogene Laherparepvec in Unresected Melanoma [Phase 2]
A Phase 2 single-arm trial evaluated the immune response to talimogene laherparepvec (T-VEC) in unresected melanoma; results completed and p…
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: Phase II Study of Tesetaxel in Metastatic Melanoma [Phase 2]
Phase II study results of Tesetaxel in metastatic melanoma have been completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma [Phase 3]
Phase 3 trial comparing Tasisulam-sodium to paclitaxel in metastatic melanoma was terminated; results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor Removal [Phase 1]
A phase 1 study evaluating tumor cell vaccines with ISCOMATRIX adjuvant and chemotherapy after tumor removal in sarcoma and melanoma has bee…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery [Phase 1]
Phase 1 trial evaluating APN401 in patients with metastatic or unresectable melanoma, pancreatic cancer, renal cell carcinoma, and other sol…
-
CLINICAL_TRIALS trial_result · 2018-06-28Clinical Trial Update: S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic Melanoma
This update confirms the completion of SWOG's S9431 trial, a study examining genes and immune responses in tumor samples from patients with …
-
CLINICAL_TRIALS trial_result · 2018-06-21Clinical Trial Update: Validation of MMS Test for Cancer Monitoring
Clinical trial validating the MMS Test for cancer monitoring has been terminated across multiple indications.
-
CLINICAL_TRIALS trial_result · 2018-06-14Clinical Trial Update: Phase 1 Study of GRN-1201 in HLA-A*02 Subjects With Resected Melanoma [Phase 1]
Phase 1 study of GRN-1201 in HLA-A*02 subjects with resected melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Study of the Variations of Albumin Level for Patients With Unresecable Stage IIIc or Stage IV Melanoma Treated by Anti BRAF and Anti MEK
Clinical trial update reports the completion of a study examining how variations in albumin levels relate to outcomes in unresectable stage …
-
CLINICAL_TRIALS trial_result · 2018-06-08Clinical Trial Update: A Two Arm Trial of Axitinib and Carboplatin/Paclitaxel in Melanoma [Phase 2]
Phase 2 two-arm trial of axitinib in combination with carboplatin/paclitaxel in melanoma has completed, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-06-07Clinical Trial Update: LC Bead Embolization Agent With Doxorubicin in the Treatment Liver Metastasis From Melanoma [NA]
Clinical trial completed evaluation of LC Bead embolization with doxorubicin for liver metastases from melanoma; results posted.
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: A Study of Tasisulam in Treating Participants With Malignant Melanoma [Phase 2]
Phase 2 trial of tasisulam in metastatic melanoma completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-05-23Clinical Trial Update: The Jules Bordet Institute Molecular Profiling Program Feasibility Trial [NA]
Feasibility trial update from the Jules Bordet Institute molecular profiling program; the study has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-16Clinical Trial Update: BKM120 Combined With Vemurafenib (PLX4032) in BRAFV600E/K Mutant Advanced Melanoma [Phase 1, Phase 2]
Phase 1/2 trial updates exploring BKM120 in combination with Vemurafenib for BRAFV600E/K-mutant metastatic melanoma has completed with resul…
-
CLINICAL_TRIALS trial_result · 2018-05-16Clinical Trial Update: Study of PX-866 and Vemurafenib in Patients With Advanced Melanoma [Phase 1, Phase 2]
This clinical trial update reports termination of a Phase 1/2 study evaluating PX-866 in combination with vemurafenib in patients with advan…
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: Addition of Ipilimumab (MDX-010) To Isolated Limb Infusion (ILI) With Standard Melphalan and Dactinomycin In The Treatment of Advanced Unresectable Melanoma of The Extremity [Phase 2]
Phase 2 clinical trial evaluating the addition of ipilimumab to isolated limb infusion with melphalan and dactinomycin for advanced unresect…
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: A Phase 1B Clinical Trial of Trametinib Plus Digoxin in Patients With Unresectable or Metastatic BRAF Wild-type Melanoma [Phase 1]
This update reports results from a Phase 1B trial evaluating the combination of trametinib and digoxin in patients with unresectable or meta…
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Phase II FANG™ in Advanced Melanoma [Phase 2]
Phase II study of FANG in advanced melanoma was terminated, with results posted in May 2018.
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery [Phase 2]
A Phase 2 trial evaluating axitinib for metastatic or unresectable melanoma (including intraocular melanoma) has been terminated. Results ha…
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples
A completed feasibility study evaluating genomic profiling methods and timing in tumor samples across several cancers, including colorectal,…
-
CLINICAL_TRIALS trial_result · 2018-05-08Clinical Trial Update: Phase I/II Study to Assess the Safety and Activity of Enhanced TCR Transduced Autologous T Cells in Metastatic Melanoma [Phase 1, Phase 2]
A Phase I/II clinical trial assessing safety and activity of enhanced TCR-transduced autologous T cells in metastatic melanoma was terminate…
-
CLINICAL_TRIALS trial_result · 2018-05-04Clinical Trial Update: Fosaprepitant for N/V With High-dose Interleukin-2 for Metastatic Melanoma and Renal Cell Carcinoma [Phase 2]
Phase 2 trial of fosaprepitant for preventing chemotherapy-related nausea and vomiting in patients receiving high-dose interleukin-2 for met…